{"id":3800,"date":"2023-03-07T15:47:36","date_gmt":"2023-03-07T15:47:36","guid":{"rendered":"https:\/\/studionazari.com\/?p=3800"},"modified":"2023-03-08T13:29:01","modified_gmt":"2023-03-08T13:29:01","slug":"la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato","status":"publish","type":"post","link":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/","title":{"rendered":"The Italian Hygiene Society in support of the monoclonal antibody Nirsevimab for the prevention of VRS disease in the newborn"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3800\" class=\"elementor elementor-3800\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"has_eae_slider elementor-section elementor-top-section elementor-element elementor-element-2b533e92 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-eae-slider=\"826\" data-id=\"2b533e92\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2cc3db85\" data-eae-slider=\"20212\" data-id=\"2cc3db85\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3df18bef elementor-widget elementor-widget-text-editor\" data-id=\"3df18bef\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"translation-block\">Following the approval by the European Medicines Agency (EMA) of the <strong>monoclonal antibody Nirsevimab for the prevention of Respiratory Syncytial Virus (VRS) in the newborn<\/strong>, the Board of the Calendar for Life - of which the Italian Hygiene Society is a member - and the Italian Society of Neonatology (SIN) are calling for its inclusion in the <strong>National Immunization Calendar<\/strong>.<\/p><p class=\"translation-block\">The Italian Society of Hygiene (SItI), the Italian Society of Pediatrics (SIP), the Italian Federation of Pediatricians (FIMP), and the Italian Federation of General Practitioners (FIMMG), which are on the <strong>Board of the Calendar for Life<\/strong>, along with the Italian Society of Neonatology (SIN) are the scientific societies that have expressed their position on the <strong>possible use of this monoclonal antibody<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"has_eae_slider elementor-section elementor-top-section elementor-element elementor-element-1afed243 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-eae-slider=\"64910\" data-id=\"1afed243\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-25aa351b\" data-eae-slider=\"2873\" data-id=\"25aa351b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-365957c0 elementor-widget elementor-widget-image\" data-id=\"365957c0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/www.studionazari.com\/wp-content\/uploads\/2022\/07\/book.svg\" class=\"attachment-large size-large wp-image-2303\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-3e683a67\" data-eae-slider=\"46076\" data-id=\"3e683a67\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3c0f6c1f elementor-widget__width-auto elementor-widget-mobile__width-inherit elementor-widget elementor-widget-heading\" data-id=\"3c0f6c1f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-small\"><a href=\"https:\/\/www.sanita24.ilsole24ore.com\/art\/medicina-e-ricerca\/2023-02-16\/virus-respiratorio-sinciziale-impatto-anticorpi-monoclonali-la-cura-preventiva-neonati-123556.php?uuid=AE7z8KoC\" target=\"_blank\">Sanit\u00e0 - Il Sole 24 Ore<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f1d484a elementor-widget__width-auto elementor-widget-mobile__width-inherit elementor-widget elementor-widget-heading\" data-id=\"f1d484a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-small\"><a href=\"https:\/\/www.nostrofiglio.it\/neonato\/cura-e-salute\/anticorpi-monoclonali-e-prevenzione-delle-malattie-da-virus-respiratorio-sinciziale\" target=\"_blank\">Nostro Figlio<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, la Societ\u00e0 Italiana d\u2019Igiene e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.<\/p>","protected":false},"author":4,"featured_media":3792,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[8],"tags":[],"class_list":["post-3800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato<\/title>\n<meta name=\"description\" content=\"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato\" \/>\n<meta property=\"og:description\" content=\"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/\" \/>\n<meta property=\"og:site_name\" content=\"Studio Nazari\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T15:47:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-08T13:29:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stefania\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stefania\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/\"},\"author\":{\"name\":\"Stefania\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#\\\/schema\\\/person\\\/70b41f3145964d2e122ede31469a1e71\"},\"headline\":\"La Societ\u00e0 Italiana d\u2019Igiene a supporto dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da VRS nel neonato\",\"datePublished\":\"2023-03-07T15:47:36+00:00\",\"dateModified\":\"2023-03-08T13:29:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/\"},\"wordCount\":146,\"publisher\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/SItI_anticorpo-monoclonale-e1678203530821.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/\",\"url\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/\",\"name\":\"La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/SItI_anticorpo-monoclonale-e1678203530821.jpg\",\"datePublished\":\"2023-03-07T15:47:36+00:00\",\"dateModified\":\"2023-03-08T13:29:01+00:00\",\"description\":\"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/SItI_anticorpo-monoclonale-e1678203530821.jpg\",\"contentUrl\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/SItI_anticorpo-monoclonale-e1678203530821.jpg\",\"width\":1200,\"height\":629},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/2023\\\/03\\\/07\\\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.studionazari.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Societ\u00e0 Italiana d\u2019Igiene a supporto dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da VRS nel neonato\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/\",\"name\":\"Studio Nazari\",\"description\":\"Media Relations &amp; Digital PR\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#organization\",\"name\":\"Studio Nazari\",\"url\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-studionazari.png\",\"contentUrl\":\"https:\\\/\\\/www.studionazari.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-studionazari.png\",\"width\":8000,\"height\":3675,\"caption\":\"Studio Nazari\"},\"image\":{\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.studionazari.com\\\/en\\\/#\\\/schema\\\/person\\\/70b41f3145964d2e122ede31469a1e71\",\"name\":\"Stefania\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g\",\"caption\":\"Stefania\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato","description":"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/","og_locale":"en_US","og_type":"article","og_title":"La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato","og_description":"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.","og_url":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/","og_site_name":"Studio Nazari","article_published_time":"2023-03-07T15:47:36+00:00","article_modified_time":"2023-03-08T13:29:01+00:00","og_image":[{"width":1200,"height":629,"url":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg","type":"image\/jpeg"}],"author":"Stefania","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Stefania","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#article","isPartOf":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/"},"author":{"name":"Stefania","@id":"https:\/\/www.studionazari.com\/en\/#\/schema\/person\/70b41f3145964d2e122ede31469a1e71"},"headline":"La Societ\u00e0 Italiana d\u2019Igiene a supporto dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da VRS nel neonato","datePublished":"2023-03-07T15:47:36+00:00","dateModified":"2023-03-08T13:29:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/"},"wordCount":146,"publisher":{"@id":"https:\/\/www.studionazari.com\/en\/#organization"},"image":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#primaryimage"},"thumbnailUrl":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/","url":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/","name":"La Societ\u00e0 Italiana d\u2019Igiene per la prevenzione delle malattie da VRS nel neonato","isPartOf":{"@id":"https:\/\/www.studionazari.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#primaryimage"},"image":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#primaryimage"},"thumbnailUrl":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg","datePublished":"2023-03-07T15:47:36+00:00","dateModified":"2023-03-08T13:29:01+00:00","description":"A seguito dell\u2019approvazione, da parte di EMA (European Medicines Agency), dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da Virus Respiratorio Sinciziale (VRS) nel neonato, il Board del Calendario per la Vita \u2013 di cui fa parte la Societ\u00e0 Italiana d\u2019Igiene \u2013 e la Societ\u00e0 Italiana di Neonatologia (SIN) ne chiedono l\u2019inserimento nel Calendario di Immunizzazione Nazionale.","breadcrumb":{"@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#primaryimage","url":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg","contentUrl":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2023\/03\/SItI_anticorpo-monoclonale-e1678203530821.jpg","width":1200,"height":629},{"@type":"BreadcrumbList","@id":"https:\/\/www.studionazari.com\/en\/2023\/03\/07\/la-societa-italiana-digiene-a-supporto-dellanticorpo-monoclonale-nirsevimab-per-la-prevenzione-delle-malattie-da-vrs-nel-neonato\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.studionazari.com\/"},{"@type":"ListItem","position":2,"name":"La Societ\u00e0 Italiana d\u2019Igiene a supporto dell\u2019anticorpo monoclonale Nirsevimab per la prevenzione delle malattie da VRS nel neonato"}]},{"@type":"WebSite","@id":"https:\/\/www.studionazari.com\/en\/#website","url":"https:\/\/www.studionazari.com\/en\/","name":"Studio Nazari","description":"Media Relations &amp; Digital PR","publisher":{"@id":"https:\/\/www.studionazari.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.studionazari.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.studionazari.com\/en\/#organization","name":"Studio Nazari","url":"https:\/\/www.studionazari.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.studionazari.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2022\/05\/logo-studionazari.png","contentUrl":"https:\/\/www.studionazari.com\/wp-content\/uploads\/2022\/05\/logo-studionazari.png","width":8000,"height":3675,"caption":"Studio Nazari"},"image":{"@id":"https:\/\/www.studionazari.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.studionazari.com\/en\/#\/schema\/person\/70b41f3145964d2e122ede31469a1e71","name":"Stefania","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fc63d4c4b6d01362f28af241436d6d119f76f2ff79225e21e89e777268b94bba?s=96&d=mm&r=g","caption":"Stefania"}}]}},"_links":{"self":[{"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/posts\/3800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/comments?post=3800"}],"version-history":[{"count":0,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/posts\/3800\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/media\/3792"}],"wp:attachment":[{"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/media?parent=3800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/categories?post=3800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.studionazari.com\/en\/wp-json\/wp\/v2\/tags?post=3800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}